Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Putting pancreatic cell plasticity to the test
Jorge Ferrer, … , Mercè Martín, Joan Marc Servitja
Jorge Ferrer, … , Mercè Martín, Joan Marc Servitja
Published April 2, 2007
Citation Information: J Clin Invest. 2007;117(4):859-862. https://doi.org/10.1172/JCI31749.
View: Text | PDF
Commentary

Putting pancreatic cell plasticity to the test

  • Text
  • PDF
Abstract

Diabetes results from the absolute or relative deficiency of insulin-producing β cells. The prospect that non-β pancreatic cells could be harnessed to become β cells has led to interest in understanding the plasticity of pancreatic cells. Recent studies, however, have shown that adult β cells are largely derived from preexisting β cells. In this issue of the JCI, Desai et al. show that acinar cells, the major cell type in the pancreas, do not contribute to new β cells formed during pancreatic regeneration (see the related article beginning on page 971). These studies suggest that the fate of adult pancreatic cell lineages is immutable. However, also in this issue of the JCI, Collombat et al. demonstrate that inducing a single transcription factor named Arx in adult β cells causes these cells to undergo massive transdifferentiation into α and pancreatic polypeptide endocrine cells (see the related article beginning on page 961). This finding points to an unexpected plasticity of postnatal pancreatic endocrine cells.

Authors

Jorge Ferrer, Mercè Martín, Joan Marc Servitja

×

Figure 1

Lineage relationships and plasticity of the embryonic and adult pancreas.

Options: View larger image (or click on image) Download as PowerPoint
Lineage relationships and plasticity of the embryonic and adult pancreas...
(A) All differentiated pancreatic epithelial lineages are derived from Pdx1+ precursor cells of the early embryonic pancreas. A subset of Pdx1+ precursors expressing Ngn3 become committed to the endocrine lineage. The transcription factors Pax4 and Arx further specify β versus α endocrine cells. (B) Given the shared developmental origin, several studies have addressed the possible interconversion of adult pancreatic lineages. For example, in vitro studies indicate that acinar cells can be differentiated into ductal or insulin-producing cells (10, 11). In this issue of the JCI, Desai et al. (9) have now demonstrated that during regeneration of the pancreas, acinar cells proliferate but do not give rise to β cells or duct cells. Together with an earlier study showing that adult β cells are largely derived from preexisting β cells (8), these findings suggest that in vivo, the plasticity of differentiated pancreatic cells is very limited. However, another study in this issue of the JCI (13) provides a clear example of pancreatic cell plasticity in vivo, showing that inducible misexpression of the transcription factor Arx in adult mature β cells causes transdifferentiation into α and PP endocrine cells. This illustrates how knowledge of developmental transcriptional mechanisms can be exploited to change cellular fates in the adult pancreas. It is conceivable, for example, that misexpression of pro–β cell specification factors such as Pax4 might be employed to generate β cells from α cells. Nkx6.1, NK6 transcription factor related, locus 1.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts